Carl Kraus
Principal investigator, leads Arrevus, Inc..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$999KFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $999K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 1, 2021 | NIH | STTR Phase I Engineered adipokine receptor inhibitor for the treatment of triple negative breast cancer in obese patients | $400K | Arrevus, Inc. with TULANE UNIVERSITY OF LOUISIANA |
| Dec 1, 2018 | NIH | STTR Phase I Development of a predictive moderate throughput assay to screen novel Designer Proline-rich antimicrobial peptide Chaperone protein inhibitors (DPCs) against multi-drug resistant pathogen | $299K | Arrevus, Inc. with MONTANA STATE UNIVERSITY - BOZEMAN |
| Jan 23, 2018 | NIH | STTR Phase I Development of a Designer Proline-rich antimicrobial peptide Chaperone protein inhibitor (DPC) for treating multi-drug resistant wound infections | $300K | Arrevus, Inc. with NORTHWESTERN UNIVERSITY AT CHICAGO |
Peer ranks
Federal funding#1,768
Awards as PI#822
Patents#273
Companies
- Arrevus, Inc.Leads (SEC Form D) · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.